Imatinib mesylate (Gleevec) induced remission in Philadelphia chromosome-negative BCR-ABL negative atypical chronic myelogenous leukemia (CML).

被引：0
|
作者：
Seftel, MD
Horsman, DE
Berry, B
Parslow, M
Pewarchuk, WJ
Nantel, SH
机构：
[1] Vancouver Gen Hosp, Leukemia BMT Program British Columbia, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[3] Capital Hlth Reg, Dept Pathol, Victoria, BC, Canada
[4] Cowichan Community Canc Ctr, Cowichan, BC, Canada
[5] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4856
引用
收藏
页码：326B / 327B
页数：2
相关论文
共 50 条
  • [31] Progression of Philadelphia positive chronic myeloid leukemia to Philadelphia negative and bcr-abl positive disease
    Zivanovic, Biljana Todoric
    Strnad, Milica
    Stamatovic, Dragana
    Elez, Marija
    CHROMOSOME RESEARCH, 2013, 21 : S105 - S106
  • [32] Allogeneic transplant for myelofibrosis, CMML and Philadelphia (Ph) chromosome negative/BCR-ABL negative CML (atypical CML): Potential survival advantage with reduced intensity regimens.
    Mittal, P
    Saliba, RM
    Giralt, SA
    Shahjahan, M
    Cohen, AI
    Karandish, S
    Champlin, RE
    De Lima, M
    BLOOD, 2002, 100 (11) : 428A - 428A
  • [33] Negativation of BCR-ABL loading in chronic myelogenous leukemia (CML) patients with sustained complete cytogenetic remission after imatinib treatment.
    Colombat, M
    Chollet, C
    Marit, G
    Roche, C
    Preudhomme, C
    Reiffers, J
    Praloran, V
    Mahon, FX
    BLOOD, 2003, 102 (11) : 417A - 417A
  • [34] Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase
    Jootar, S.
    BLOOD REVIEWS, 2007, 21 : S121 - S121
  • [35] EVOLUTION OF KARYOTYPES IN PHILADELPHIA (PH1) CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA
    MINTZ, U
    VARDIMAN, J
    GOLOMB, HM
    ROWLEY, JD
    CANCER, 1979, 43 (02) : 411 - 416
  • [36] Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate
    M E O'Dwyer
    K M Gatter
    M Loriaux
    B J Druker
    S B Olson
    R E Magenis
    H Lawce
    M J Mauro
    R T Maziarz
    R M Braziel
    Leukemia, 2003, 17 : 481 - 487
  • [37] Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate
    O'Dwyer, ME
    Gatter, KM
    Loriaux, M
    Druker, BJ
    Olson, SB
    Magenis, RE
    Lawce, H
    Mauro, MJ
    Maziarz, RT
    Braziel, RM
    LEUKEMIA, 2003, 17 (03) : 481 - 487
  • [38] Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia
    Carella, AM
    Lerma, E
    Corsetti, MT
    Dejana, A
    Basta, P
    Vassallo, F
    Abate, M
    Soracco, M
    Benvenuto, F
    Figari, O
    Podestà, M
    Piaggio, G
    Ferrara, R
    Sessarego, M
    Parodi, C
    Pizzuti, M
    Rubagotti, A
    Occhini, D
    Frassoni, F
    BLOOD, 1999, 93 (05) : 1534 - 1539
  • [39] Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
    Elias, Marjanu Hikmah
    Baba, Abdul Aziz
    Husin, Azlan
    Abdullah, Abu Dzarr
    Hassan, Rosline
    Sim, Goh Ai
    Wahid, S. Fadilah Abdul
    Ankathil, Ravindran
    HEMATOLOGY REPORTS, 2012, 4 (04) : 86 - 90
  • [40] Philadelphia chromosome without expression of BCR-ABL chimeric gene in a chronic myelogenous leukemia (CML) after bone marrow transplantation.
    Bonomi, R
    Moreno, P
    Gabús, R
    Zamora, M
    Uriarte, R
    BLOOD, 2000, 96 (11) : 186B - 186B
12345